SMAD3 and type 2 diabetes mellitus: Experimental study shows that sEVs from bone marrow stem cells increase the gene expression of insulin signal pathway (insulin, Pdx1, Smad2, Smad3, and transforming growth factor β) in the type 1 diabetes condition and alleviate insulin resistance in the T2D rat model.19, 20